Vock Christina, Hauber Hans-Peter, Wegmann Michael
Department of Experimental Pneumology, Research Center Borstel, 23845 Borstel, Germany.
J Allergy (Cairo). 2010;2010:519298. doi: 10.1155/2010/519298. Epub 2010 Jul 25.
The complex phenotype of allergic bronchial asthma involves a variable degree of bronchoobstruction, increased mucus production, and airway remodeling. So far it is suggested that it arises from multiple interactions of infiltrating and structural cells in the context of chronic airway inflammation that is orchestrated by T helper 2 (TH2) cells. By secreting a plethora of typical mediators such as interleukin (IL) 4, IL-5, and IL-13, these cells hold a key position in asthma pathogenesis. However, therapeutic approaches targeting these TH2-type mediators failed to improve asthma symptoms and impressively showed that asthma pathogenesis cannot be reduced by TH2 cell functions. Recently, other T helper cells, that is, TH9 and TH17 cells, have been identified and these cells also contribute to asthma pathogenesis, the processes leading to formation or aggravation of asthma. Furthermore, TH25 cells, TH3 cells, and regulatory T cells have also been implicated in asthma pathogenesis. This paper aims at summarizing recent insights about these new T helper cells in asthma pathogenesis.
过敏性支气管哮喘的复杂表型涉及不同程度的支气管阻塞、黏液分泌增加和气道重塑。目前认为,它源于在由辅助性T细胞2(TH2)细胞协调的慢性气道炎症背景下,浸润细胞与结构细胞的多种相互作用。通过分泌大量典型介质,如白细胞介素(IL)4、IL-5和IL-13,这些细胞在哮喘发病机制中占据关键地位。然而,针对这些TH2型介质的治疗方法未能改善哮喘症状,并且令人印象深刻地表明,哮喘发病机制不能通过TH2细胞功能来简化。最近,已鉴定出其他辅助性T细胞,即TH9和TH17细胞,并且这些细胞也参与哮喘发病机制,即导致哮喘形成或加重的过程。此外,TH25细胞、TH3细胞和调节性T细胞也与哮喘发病机制有关。本文旨在总结关于这些新型辅助性T细胞在哮喘发病机制中的最新见解。